News About: Pharm. Industry
AstraZeneca’s Crestor to be exposed to cutthroat competition
AstraZeneca (AZ)’s Crestor (rosuvastatin) will not be as stable as before with a growing number of pharmaceutical companies poising to enter a 50 billion Crestor market.
A total of 60 pharmaceutical manufacturers ...
Report on glucosamine supplement stirs heated debate
A new report showed that the highly praised dietary supplement, glucosamine, or glucosamine sulfate, is useless in treatment of mild to moderate osteoarthritis.
The report, which was released on February 2 by the N...
Yooyoung signs marketing agreement for novel combination of pravastatin and fenofibrate
Yooyoung Pharm says it has recently entered into an exclusive agreement with Belgium based 'LABORATOIRES SMB S.A. to locally market Pravafen, a combination of fenofibrate and pravastatin to treat mixed dyslipidemia.
...
Local drugmakers urged to join W1 trillion club in sales
Many say Korean pharmaceutical companies should go all-out to reach “1-trillion-won club'' in sales in the near future.
The potential drug maker to achieve this record is Dong-A Pharm, which exceeded 800 billion in...
KFDA simplifies vendor audit procedures
Drug makers will share the contents of a vendor audit if they purchase raw material from the same supplier, the Korea Food and Drug Administration said.
Under the current cGMP (current Good Manufacturing Practice) ...
Yuhan to market Zirtec
Yuhan Corporation said the company will market UCB’s popular antihistamine drug Zirtec (cetirizine) for the next five years here as it took over its marketing right from Samil Pharm.
Yuhan will step up their market...
More tax exemptions set for R&D spending
Korea seeks to expand tax exemptions for corporate investment in research and development (R&D) as part of efforts to stimulate state-run and private companies’ R&D spending in the era of free trade agreements (FTAs)....
Samil invites foreign CEO
Samil Pharm said on January 29 that it has appointed Indian-born Villur Sundararajan Ram as its new chief executive officer.
Samil official said it is Korea's first pharmaceutical company to choose a non-Korean nat...
Neuronex gets US FDA GLP certification
Local biopharmaceutical firm Neuronex Co. has recently passed the GLP (Good Laboratory Practice) skin irritation test of the US Food and Drug Administration over its new topical treatment for Raynaud's disease, accord...
Suh Kyung-bae renamed as head of Korea Cosmetic Association
AmorePacific CEO Suh Kyung-bae has recently renamed as chariman of the Korea Cosmetic Association (KCA), company representatives said.
Seo was reappointed to lead the regional body for his fullest support to improv...
